FAAH and Alzheimer disease: Remarkably, the phenotypical characterization of AD-related changes in human patients revealed that FAAH is specifically upregulated in peripheral blood mononuclear cells [7] and in the hippocampus and entorhinal cortex [11], suggesting a prominent role of this enzyme in human AD.